pharmas

Sun Pharmaceutical Industries (Sun Pharma) reported a turnaround in the January-March quarter of the 2022-23 financial year (Q4FY23), declaring a profit after tax (PAT) of Rs 1,984 crore versus a loss of Rs 2,277 crore in Q4FY22.…

The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations. (Representative image)The company made its debut on the stock exchanges on Tuesday. It also launched its IPO this year. …

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels. Analysts feel that revenue and EBIDTA growth in the pharmaceutical sector would be in the range of 14-21 per cent in the fourth quarter of the 2022-23…

The federal government says it hasn't closed the door on pursuing criminal charges against pharmaceutical companies over their alleged involvement in the opioid crisis — but such charges would result only in minimal fines.While the province…

Representational image only. | Photo Credit: Special Arrangement Dr. Reddy’s Laboratories (DRL) is acquiring the U.S. generic prescription product portfolio of Australia’s Mayne Pharma Group for $105 million, which includes an upfront cash…

A new weight-loss drug made by Eli Lilly is set to become the best selling medicine of all time, analysts predict.Tirzepatide — sold under the brand name Mounjaro — is expected to be approved by the Food and Drug Administration (FDA) for…

Sun Pharmaceutical Industries Ltd. on Thursday said its Halol facility in Gujarat had been listed under import alert by the U.S. FDA with products manufactured at the unit now are subject to refusal of admission in the U.S. market.The…

Sun Pharmaceutical Industries Ltd on Thursday said its Halol facility in Gujarat has been listed under import alert by the USFDA with products manufactured at the unit now are subject to refusal of admission in the US market. Photograph:…

<!-- -->The shares of the pharmaceutical company closed at Rs 488 apiece on Friday on BSE.Hyderabad: Aurobindo Pharma has posted a decline of 41 per cent in its net profit to Rs 409 crore in the quarter ended September against Rs 697…

The Disney+ Hotstar series Human is a bombastic indictment of the pharmaceutical industry and private healthcare’s ravenous appetite for profit at the cost of human lives. A pharma giant and an elite private hospital collude to fast track…